NCT01036009 A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT01026376 An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS) Status NO_LONGER_AVAILABLE Phase N/A
NCT01015352 Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA) Status COMPLETED Phase PHASE2
NCT01011283 To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. Status TERMINATED Phase PHASE4
NCT01009502 Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome Status TERMINATED Phase PHASE1
NCT00997243 Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes Status TERMINATED Phase PHASE2
NCT00996359 Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation Status TERMINATED Phase PHASE1
NCT00996047 S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers Status COMPLETED Phase N/A
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone Status COMPLETED Phase N/A
NCT00987584 Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk Status COMPLETED Phase N/A
NCT00986804 Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant Status COMPLETED Phase PHASE1
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant Status COMPLETED Phase N/A
NCT00963872 Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00961064 A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00952185 Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers Status TERMINATED Phase NA
NCT00949117 Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer Status TERMINATED Phase PHASE2